Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetic Modifiers for 22q11.2 Syndrome

NCT00916955 is registered in ClinicalTrials.gov with State University of New York - Upstate Medical University as lead sponsor.

NCT NCT00916955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00916955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetic Modifiers for 22q11.2 Syndrome
Lead sponsor
State University of New York - Upstate Medical University
Phase
Observational
Overall status
Completed
Start date
March 31, 2008
Completion date
February 28, 2015
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

22q11.2 deletion syndrome